share_log

国邦医药(605507.SH):浙民投恒华、丝路基金累计减持1.82%股份

Guobang Pharmaceutical (605507.SH): Zhejiang Minjin Henghua and Silk Road Fund reduced their holdings by a total of 1.82%

Gelonghui Finance ·  May 8 07:16

Gelonghui, May 8, 丨 Guobang Pharmaceutical (605507.SH) announced that it has received a “Notice Letter on the Progress of the Shareholding Reduction Plan and Changes in Equity by More than 1%” from Zhejiang Minjin Investment Henghua and Silk Road Fund. The current holdings reduction plan reduced the company's holdings by a total of 10,171,800 shares, with a change ratio of 1.82% of the company's total share capital. The amount of holdings reduction this time is over half. The current holdings reduction plan has not yet been implemented. After this change in equity, Zhejiang Mintou Henghua and Silk Road Fund held 20,887,083 shares of the company, accounting for 3.74% of the company's total share capital.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment